135 related articles for article (PubMed ID: 38103305)
1. Development and validation of an LC-MS/MS method for the quantification of KRAS
Retmana IA; Çelebi N; Rijmers J; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123964. PubMed ID: 38103305
[TBL] [Abstract][Full Text] [Related]
2. Validated LC-MS/MS method for simultaneous quantification of KRAS
Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
J Pharm Biomed Anal; 2023 Oct; 235():115612. PubMed ID: 37557065
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of an LC-MS/MS method for the quantitative analysis of milciclib in human and mouse plasma, mouse tissue homogenates and tissue culture medium.
Martínez-Chávez A; Tibben MM; Broeders J; Rosing H; Schinkel AH; Beijnen JH
J Pharm Biomed Anal; 2020 Oct; 190():113516. PubMed ID: 32784092
[TBL] [Abstract][Full Text] [Related]
4. Quantification of KRAS inhibitor sotorasib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122718. PubMed ID: 33957355
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an HPLC-MS/MS method to quantify the KRAS inhibitor adagrasib in mouse plasma and tissue-related matrices.
Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
Biomed Chromatogr; 2023 Nov; 37(11):e5720. PubMed ID: 37596864
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium.
Bruin MAC; Rosing H; Lucas L; Wang J; Huitema ADR; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121723. PubMed ID: 31352204
[TBL] [Abstract][Full Text] [Related]
7. Quantification of FGFR4 inhibitor BLU-554 in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Dogan-Topal B; Li W; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():116-123. PubMed ID: 30802754
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 attenuates brain exposure to the KRAS
Rijmers J; Retmana IA; Bui V; Arguedas D; Lebre MC; Sparidans RW; Beijnen JH; Schinkel AH
Biomed Pharmacother; 2024 May; 175():116720. PubMed ID: 38733773
[TBL] [Abstract][Full Text] [Related]
9. Validation of an LC-MS/MS method for the determination of sotorasib, a KRAS
Wong P; Akrami A; Houk B; Vuu I; James CA
Bioanalysis; 2022 Oct; 14(19):1281-1292. PubMed ID: 36473022
[No Abstract] [Full Text] [Related]
10. Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry.
Martínez-Chávez A; Rosing H; Hillebrand M; Tibben M; Schinkel AH; Beijnen JH
Anal Bioanal Chem; 2019 Aug; 411(20):5331-5345. PubMed ID: 31209549
[TBL] [Abstract][Full Text] [Related]
11. Quantitative bioanalytical assay for the tropomyosin receptor kinase inhibitor larotrectinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Sparidans RW; Wang Y; Schinkel AH; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():167-172. PubMed ID: 30396050
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an LC-MS/MS assay for the quantification of cintirorgon (LYC-55716) in mouse plasma and tissue homogenates.
Heydari P; Li W; Schinkel AH; Beijnen JH; Sparidans RW
J Pharm Biomed Anal; 2022 Jan; 207():114421. PubMed ID: 34710729
[TBL] [Abstract][Full Text] [Related]
13. Quantitative bioanalytical assay for the selective RET inhibitors selpercatinib and pralsetinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Şentürk R; Wang Y; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1147():122131. PubMed ID: 32416592
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an LC-MS/MS method for the determination of AZD7648 in rat plasma: Application to a pharmacokinetic study.
Fang X; Lu Q; Han J
Biomed Chromatogr; 2024 Jan; 38(1):e5765. PubMed ID: 37845175
[TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of a sensitive LC-MS/MS method for the quantification of KRAS
Wang Y; Wang Z; Wang X; Li X; Liu X; Zhang X; Liu S
Biomed Chromatogr; 2023 Jun; 37(6):e5629. PubMed ID: 36945141
[TBL] [Abstract][Full Text] [Related]
17. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
[TBL] [Abstract][Full Text] [Related]
18. Bioanalytical assay for the new-generation ROS1/TRK/ALK inhibitor repotrectinib in mouse plasma and tissue homogenate using liquid chromatography-tandem mass spectrometry.
Li W; Perpinioti N; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122098. PubMed ID: 32278292
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
Gao H; Cheng M; Liu H; Ding L
J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a high-throughput method for the quantitative analysis of D-amphetamine in rat blood using liquid chromatography/MS3 on a hybrid triple quadrupole-linear ion trap mass spectrometer and its application to a pharmacokinetic study.
Cesari N; Fontana S; Montanari D; Braggio S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):21-8. PubMed ID: 19945359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
